Ani Pharmaceuticals (ANIP) Return on Sales [ROS] (2011 - 2026)
Ani Pharmaceuticals (ANIP) posted Return on Sales [ROS] of 15.21% for Q2 2026, up 8.64 percentage points from 6.57% a year earlier but down 1.17 percentage points from the prior quarter.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Return on Sales [ROS] (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Ani Pharmaceuticals was 15.37%, up 13.34 percentage points year-over-year; for FY2025, it came in at 12.58%, up 12.48 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of +20.26 percentage points (FY2020 to FY2025).
- In prior years, Ani Pharmaceuticals' Return on Sales [ROS] was 0.10% in FY2024 (-9.55 pp), 9.65% in FY2023 (+20.80 pp), -11.15% in FY2022 (+7.26 pp) and -18.41% in FY2021 (-10.73 pp).
- Quarterly Return on Sales [ROS] has run from a low of -38.94% in Q4 2021 to a high of 16.38% in Q1 2026 over five years.
- On a year-over-year basis, Return on Sales [ROS] has increased in each of the last five quarters, with an average year-over-year change of +3.04 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2022, with a gain of 40.87 percentage points; the weakest was Q4 2021, with a drop of 39.51 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 16.38% (Q1 2026), 14.07% (Q4 2025) and 15.91% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 32.98% |
| 10 | Ani Pharmaceuticals | 1.43 Bn | 212.92 Mn | 165.89 Mn | 15.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.21% |
| Mar 31, 2026 | 16.38% |
| Dec 31, 2025 | 14.07% |
| Sep 30, 2025 | 15.91% |
| Jun 30, 2025 | 6.57% |
| Mar 31, 2025 | 13.29% |
| Dec 31, 2024 | -2.30% |
| Sep 30, 2024 | -13.83% |
| Jun 30, 2024 | 3.74% |
| Mar 31, 2024 | 14.78% |
| Dec 31, 2023 | 5.11% |
| Sep 30, 2023 | 13.61% |
| Jun 30, 2023 | 10.64% |
| Mar 31, 2023 | 9.27% |
| Dec 31, 2022 | 1.93% |
| Sep 30, 2022 | -5.96% |
| Jun 30, 2022 | -17.48% |
| Mar 31, 2022 | -29.77% |
| Dec 31, 2021 | -38.94% |
| Sep 30, 2021 | -6.84% |
API Access
Ani Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ANIP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();